Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
09/2001
09/27/2001WO2001070685A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
09/27/2001WO2001070684A2 Peptidomimetic ligands for cellular receptors and ion channels
09/27/2001WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives
09/27/2001WO2001070675A2 Inhibitors of histone deacetylase
09/27/2001WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a)
09/27/2001WO2001070671A2 Insecticidal anthranilamides
09/27/2001WO2001070668A2 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
09/27/2001WO2001070226A1 Novel processes for preparing torsemide intermediate
09/27/2001WO2001062705A8 Aminoalcohol derivatives
09/27/2001WO2001060822A8 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
09/27/2001WO2001004115A3 Novel process for synthesis of heteroaryl-substituted urea compounds
09/27/2001US20010025051 Administering to a breast cancer patient an effective amount of hydroxy containing bicyclic aromatic or heteroaromatic derivatives
09/27/2001US20010024749 Surface modified carbonaceous materials
09/27/2001DE10014006A1 New heterocyclic acylsulfimide derivatives, useful as insecticides, acaricides and nematocides for plant protection or in veterinary medicine
09/27/2001CA2723664A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
09/27/2001CA2404002A1 Inhibitors of histone deacetylase
09/27/2001CA2403828A1 Inhibitors of p38
09/27/2001CA2403823A1 Thioketals and thioethers for inhibiting the expression of vcam-1
09/27/2001CA2403805A1 Amines substituted with a dihydronaphthalenyl, crhomenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity
09/27/2001CA2403382A1 Novel processes for preparing torsemide intermediate
09/27/2001CA2401908A1 Amorphous torasemide modification
09/27/2001CA2401870A1 Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-.alpha.
09/27/2001CA2401728A1 Difluorobutyric acid metalloprotease inhibitors
09/27/2001CA2391316A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
09/27/2001CA2364268A1 Di-substituted iminoheterocyclic compounds
09/26/2001EP1136470A1 Process for the preparation of a piperazine derivative
09/26/2001EP1135378A1 Benzamide derivatives and their use as apob-100 secretion inhibitors
09/26/2001EP1135377A1 Novel compounds
09/26/2001EP1135371A1 Beta-alanine derivatives as alpha 4 integrin inhibitors
09/26/2001EP1135365A1 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction
09/26/2001EP1135364A1 Substituted oximes
09/26/2001EP1135134A1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
09/26/2001EP1031570A4 Immuno-modulator exhibiting anti-microbial and anti-mycobacterial activities, method for producing the same and pharmaceutical preparation for treating mycobacterioses as well as lung chronic and non specific conditions, sexually transmitted diseases and the resulting immuno-deficiency
09/26/2001EP0900214B1 Process for preparation of pyrimidine derivatives
09/26/2001EP0800505B1 Novel immunotherapeutic aryl amides
09/26/2001CN1314890A Cyanoguanidines as cell proliferation inhibitors
09/26/2001CN1314889A Chemical process for preparing 2-hydroxy-6-trifluoro methylpyridine
09/26/2001CN1314884A 2,5-substituted benzoluslfonylureas and thioureas, methods for production thereof, use thereof and pharamceutical preparations containing the same
09/26/2001CN1314883A Amino acid derivatives and drug containing the same as the active ingredient
09/26/2001CN1314882A NAALADase inhibitors useful as pharmaceutical compound and compositions
09/26/2001CN1314346A Process for preparing radio-therapeutic sensitivity intensifier 2-substituted amino-3-cyano-5-nitropyridine
09/26/2001CN1071751C Reversible protease inhibitors
09/26/2001CN1071738C Carboxylic derivatives exhibiting phospholipase A2 inhibitory activity
09/25/2001US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure
09/25/2001US6294569 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject.
09/25/2001US6294557 Analgesic at central nervous system in the mammalian subject. also, these compounds are inflammatory pain caused, for example by burns (induced by a contact with heat, acid or the other rheumatism or the like, in the said subject.
09/25/2001US6294069 Method for preparing 2-aryl or 2-heterocyclyl chiral propionic acids and their esters
09/25/2001CA2091005C Microbiological process for hydroxylation of nitrogen-heterocyclic-carboxylic acids
09/20/2001WO2001068664A2 Mass labels
09/20/2001WO2001068657A1 Triphenylphosphine derivative, production process therefor, palladium complex thereof, and process for producing biaryl derivative
09/20/2001WO2001068645A2 N-cyanomethylcarboxamides and their use as protease inhibitors
09/20/2001WO2001068619A1 5-amide substituted diarylamines as mex inhibitors
09/20/2001WO2001068612A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
09/20/2001WO2001068608A1 -diketonato-metal complexes and process for the preparation thereof, photoelectric conversion devices and photoelectrochemical cells
09/20/2001WO2001068607A1 Amide compounds and use thereof
09/20/2001WO2001068605A1 Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
09/20/2001WO2001068600A2 Benzylated pde4 inhibitors
09/20/2001WO2001068599A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
09/20/2001WO2001068586A2 α4β1 AND α4β7 INTEGRIN INHIBITORS
09/20/2001WO2001068585A1 Novel amide compounds
09/20/2001WO2001068568A2 Il-8 receptor antagonists
09/20/2001WO2001068094A1 Heme oxygenase-1 inducers or induction enhancers
09/20/2001WO2000071506A9 Naphthalene ureas as glucose uptake enhancers
09/20/2001WO2000047553A8 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
09/20/2001US20010023259 Nutrients, drugs
09/20/2001US20010023240 Compounds and compositions for delivering active agents
09/20/2001US20010022987 Flowable pellets containing nicotinamide and process for the production thereof
09/20/2001CA2403017A1 5-amide substituted diarylamines as mex inhibitors
09/20/2001CA2402891A1 Il-8 receptor antagonists
09/20/2001CA2402746A1 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
09/20/2001CA2402384A1 Benzylated pde4 inhibitors
09/19/2001EP1134219A1 Cycloalkyl-substituted aminomethylpyrrolidine derivatives
09/19/2001EP1134214A1 Picolinamide derivatives and pest controllers containing the same as the active ingredient
09/19/2001EP1133471A1 Hydrazine derivatives
09/19/2001EP0612244B1 Endothelin receptor antagonists
09/19/2001CN1071361C Fibre-reactive dyestuffs
09/19/2001CN1071325C Thiol derivatives with metallopeptidase inhibitory activity
09/19/2001CN1071322C Process for producing 5,6-dihydro-1,3-oxazines
09/19/2001CN1071320C Preparation of arylamides of heteroaromatic carboxylic acids
09/19/2001CN1071315C Carbamate compounds and processes for preparing the same
09/19/2001CN1071311C Process for manufacturing nitriles
09/18/2001US6291687 Used aspartyl protease inhibitors of human immunodeficiency virus (hiv)
09/18/2001US6291678 Process for the preparation of chiral keto-heterocycles of basic amino acids
09/18/2001US6291530 Aryl-substituted acrylamides with Leukotriene B4 (LTB-4) receptor antagonist activity
09/18/2001US6291508 Potent ability to bind to retinoic acid receptors thus useful in treating psoriasis and rheumatoid arthritis.
09/18/2001US6291503 β-phenylalanine derivatives as integrin antagonists
09/18/2001US6291500 Administering an antifungal agent
09/18/2001US6291491 Treatment of type ii diabetes and obesity; antidepressants; decrease gut motility.
09/18/2001US6291489 Process for substituted pyridines
09/18/2001US6291464 Aminopiperazine derivatives
09/13/2001WO2001066534A2 Cyclic and bicyclic diamino histamine-3 receptor antagonists
09/13/2001WO2001066524A2 Intermediates useful for the synthesis of huperzine a
09/13/2001WO2001066523A1 6-chloro-3-pyridylmethylpropylamine derivatives, preparation process thereof and bactericides
09/13/2001WO2001066522A1 Acylated phenyl or pyridine herbicides
09/13/2001WO2001012615A3 Fungicidal heteroaryl hepta-2,6-dienoic acid derivatives
09/13/2001WO2000032573A8 A meta-nitro phenol derivative and a process for producing it
09/13/2001US20010021778 Oxidizing a 4-phenyl-N-acyldihydropyridine
09/13/2001US20010021717 Hydroxylation activated prodrugs
09/13/2001US20010021716 Using agonist of nicotinergic acetylcholine receptors
09/13/2001US20010021715 Gastrointestinal disorders